Home » Topics » BioWorld Science

BioWorld Science
RSS

China's NMPA issues clinical trial approval for JS-103 for gout

May 13, 2021

Mabwell initiates first-in-human study of 9MW-1411

May 13, 2021

Inovio reports preclinical data on next-generation pan-COVID-19 vaccine candidate INO-4802

May 13, 2021

Mitsubishi Tanabe discontinues development of MT-5745 for ulcerative colitis

May 13, 2021

New phase II trial evaluates CBP-201 for moderate to severe persistent asthma

May 13, 2021

Nephraegis Therapeutics to develop NPH-022 for the prevention and treatment of AKI

May 13, 2021

Full-data analysis from 12-month treatment phase of ALTISSIMO study in wet AMD

May 13, 2021

New Angex Pharmaceutical anticancer compounds show preclinical potential

May 13, 2021

ShanghaiTech University, Fudan University patent new PROTACs

May 13, 2021

Suzhou Raymon Pharmaceuticals discovers PI3K-alpha inhibitors

May 13, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...